Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McClellan’s “Strong FDA” Is Unfazed By Device Appropriations Shortfall

This article was originally published in The Gray Sheet

Executive Summary

FDA is assuring medical device execs that the Bush Administration is united in seeking the additional appropriations required by MDUFMA, but cannot guarantee that funding benchmarks will be met by 2004

You may also be interested in...



FDA Fingerprints On MDUFMA Trigger? MDMA Holds Hill To Funding Targets

A revision of the "trigger" within the Medical Device User Fee & Modernization Act to account for appropriations shortfalls would represent a breach of the original agreement by Congress, FDA and industry, the Medical Device Manufacturers Association contends

FDA Fingerprints On MDUFMA Trigger? MDMA Holds Hill To Funding Targets

A revision of the "trigger" within the Medical Device User Fee & Modernization Act to account for appropriations shortfalls would represent a breach of the original agreement by Congress, FDA and industry, the Medical Device Manufacturers Association contends

User Fees Hiked In FY ’04: Fewer Submissions, Bundling Cited As Factors

PMA submission trends over the next 12 months will help determine whether device user fees in fiscal 2005 continue to rise at the FY 2004 rate

Related Content

UsernamePublicRestriction

Register

SC143367

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel